The White House today announced landmark drug pricing agreements with Eli Lilly and Company and Novo Nordisk to lower the ...

Panelists discuss how accurate and early diagnosis remains one of the most difficult challenges in schizophrenia care. Many ...

Panelists discuss how pharmacy-driven barriers, including delayed statin initiation and failure to escalate therapy, ...

Panelists discuss how genetic predisposition is a major determinant in schizophrenia risk, with heritability playing a ...

Chronic urticaria affects 17% of patients, with higher age, elevated BMI, and early prednisolone use as key determinants of prolonged disease duration. The study utilized data from the Julius General ...

Ritlecitinib effectively reduces psychosocial burden in severe alopecia areata, beyond hair regrowth benefits. Significant improvements in emotional symptoms and activity limitations were observed ...

These 3 studies, to be presented at the American Heart Association (AHA) Scientific Sessions 2025, explored how these interventions can help reduce cardiovascular and cognitive risks in adults with ...

A national survey found 13.1% of US youths use generative AI for mental health advice, with higher usage among those aged 18 to 21. Most users found AI advice helpful, but Black respondents were less ...

Syndromic real-time PCR tests for respiratory infections provide economic advantages by improving healthcare utilization and reducing costs.

A new option is now approved to treat adults living with high-risk smoldering multiple myeloma (MM). 1 The FDA has greenlit ...

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...

CMS introduced the GENEROUS Model to reduce Medicaid drug costs, enhance access, and improve health outcomes for ...